Details for New Drug Application (NDA): 211181
✉ Email this page to a colleague
The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 211181
Tradename: | PYRIDOSTIGMINE BROMIDE |
Applicant: | Mlv |
Ingredient: | pyridostigmine bromide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211181
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 211181
Suppliers and Packaging for NDA: 211181
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET;ORAL | 211181 | ANDA | Method Pharmaceuticals, LLC | 58657-810 | 58657-810-21 | 21 TABLET in 1 BOTTLE (58657-810-21) |
PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET;ORAL | 211181 | ANDA | Method Pharmaceuticals, LLC | 58657-811 | 58657-811-01 | 100 TABLET in 1 BOTTLE (58657-811-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Jul 20, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
Approval Date: | May 14, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription